RBC Capital Views Mylan's (MYL) Meda Purchase as Desperate - PT to $58
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Mylan (MYL) Shares Look to Stabilize After Pounding on 'Desparate' Meda Deal
February 11, 2016 11:09 AM ESTMylan (NASDAQ: MYL) is attempting to stabilize as investors express disappointment with the Meda deal, sending the stock in free-fall. Analysts called the deal,... More
Mylan (MYL) Miss Overshadowed by Mediocre Deal - Guggenheim
February 11, 2016 8:07 AM ESTAfter the 4Q15 miss and announcement of the deal to acquire Meda Guggenheim analyst, Louise Chen, remains on the sidelines and kept her Neutral rating on Mylan (NASDAQ: MYL) shares. This acquisition makes strategic sense, but Meda (3% topline, 5% EBITDA growth) does not enhance MYL's sales and earnings profile. This is important ahead of potential generic competition for Epipen in 2H16. No change to... More
After-Hours Stock Movers 02/10: (HUBS) (EXPE) (TSLA) Higher; (PPC) (MYL) (ZNGA) Lower (more...)
February 10, 2016 6:10 PM ESTHubSpot (NYSE: HUBS) 13.3% HIGHER; reported Q4 EPS of ($0.12), $0.06 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $53.1 million versus the consensus estimate of $50.34 million. GUIDANCE: HubSpot sees FY2016 EPS of ($0.78)-($0.66), versus the consensus of ($0.73). HubSpot sees FY2016 revenue of $248-251 million, versus the consensus of $241.0 million.
Expedia (NASDAQ: EXPE) 11.9% HIGHER; reported Q4 EPS of $0.77, $0.23 worse than the analyst estimate of $1.00. Revenue for the quarter came in at $1.7 billion versus the consensus estimate of $1.71... More
Mylan to buy Swedish drugmaker Meda in $7.2 billion deal
February 10, 2016 4:49 PM ESTBy Natalie Grover
(Reuters) - Generic drugmaker Mylan NV (NASDAQ: MYL) said it would acquire Meda AB in a $7.2 billion cash-and-stock deal in its third attempt to buy the Swedish company.
The move comes three months after Mylan gave up on its seven-month-long pursuit of smaller rival Perrigo (NYSE: PRGO).
Mylan's stock fell about 8 pct in extended trading, after it announced the 165 Swedish crowns per share offer. That works out to be nearly twice Meda's last traded price, which had some analysts... More
Mylan (MYL) Misses Q4 EPS by 5c
February 10, 2016 4:13 PM ESTMylan (NASDAQ: MYL) reported Q4 EPS of $1.22, $0.05 worse than the analyst estimate of $1.27. Revenue for the quarter came in at $2.49 billion versus the consensus estimate of $2.7 billion.
GUIDANCE:
Mylan sees FY2016 EPS of $4.85-$5.15, versus the consensus of $4.90.
For earnings history and earnings-related data on Mylan (MYL) click here.
... MoreMylan (MYL) Enters Agreement to Acquire Meda in ~$9.9B Deal
February 10, 2016 4:03 PM ESTPrice of SEK 165 per Meda Share at Announcement Represents a Multiple of Approximately 12.9x 2015 Adjusted EBITDA and 8.9x 2015 Adjusted EBITDA with Synergies
Strengthens Mylan's Position as a Diversified Global Pharmaceutical Leader with an Expansive and Growing Portfolio of Specialty, Generic and OTC Products and a Strong, Complementary Therapeutic Presence
Combined Business Will Have Critical Mass across Commercial Channels in Europe, a Leading U.S. Specialty Business, and an Exciting Platform for Growth in Emerging Markets
Expected to Be Immediately Accretive to Mylan Earnings, with Accretion Increasing Significantly after First Full Year (2017) as Synergies Are Realized; Creates... More
Mylan (MYL) to Announce Takeover of Meda - FT
February 10, 2016 3:47 PM ESTMylan (NASDAQ: MYL) is set to announce a takeover of Meda, according to the Financial Times. An announcement could come later today.
... MoreTrading Radar for 2/10: Twitter (TWTR), Time Warner (TWX), Tesla (TSLA), Cisco (CSCO), Humana (HUM) Report
February 9, 2016 3:13 PM ESTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
7:00am EST
Earnings:
ACCO Brands Corporation (Nasdaq: ACCO) - consensus EPS $0.28
ARM Holdings plc (Nasdaq: ARMH) - consensus EPS $0.38
AmTrust Financial (Nasdaq: AFSI) - consensus EPS $0.67
Aramark Services (Nasdaq: ARMK) - consensus EPS $0.49
Axalta Coating Systems (Nasdaq:... More

